Not to toot my own horn (ok, maybe an itty bitty Mini Cooper horn), but I called for NP to invest in PR this week and boy did he deliver! Figure out a way to get on National TV to take advantage of the buzz around experimental COVID treatments. Mission accomplished.

Quote:

---

This is why I mentioned media coverage last night. Certainly not a commercial and not necessarily involving Nader or anyone live on air. An effective PR person has connections and access to media outlets and reporters and certainly right now, COVID treatments IN TRIALS are on topic, especially after Trump's speech today.

As was mentioned, now is the time to strike while the iron is hot. It's not about bumping up share price, it's all about bumping up name recognition for leronlimab to coincide with current events and the impending CD12 interim readout.

---